Media

Vicore Pharma – Interim Report July – September 2025

Oncopeptides publishes Q3 report 2025

Pretzel Therapeutics Presents Preclinical Data Supporting POLRMT as a Novel Target for the Treatment of Metabolic Disease at ObesityWeek 2025

Research by top universities together with Oncopeptides on NK cell engagers to be presented at ASH

Oncopeptides – Invitation to presentation of the Q3 report 2025

The Neuron Clinic Becomes First Neurology Office to Implement Positrigo’s NeuroLF for Point-of-Care Brain PET Imaging

Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders

Kivu Bioscience Appoints Sophia Randolph, M.D., Chief Medical Officer

Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051

10 Years of HelloBetter: Psychological AI Companion Marks First Step Toward Integrated Mental Health Care